EZZ Life Science Holdings Limited (ASX:EZZ)

EZZ Life Science Holdings Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 5, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	71	82	21	13	19	-
Market Cap Growth	421.73%	283.76%	61.08%	-29.08%	-	-
Enterprise Value	51	70	12	4	15	-
Last Close Price	1.50	1.81	0.48	0.28	0.41	-
PE Ratio	7.38	11.77	5.88	10.10	9.20	-
Forward PE	8.47	7.87	8.13	-	-	-
PS Ratio	0.94	1.23	0.57	0.88	0.84	-
PB Ratio	2.94	3.84	1.46	1.16	1.85	-
P/TBV Ratio	2.95	3.85	1.47	1.17	1.85	-
P/FCF Ratio	8.94	14.29	5.46	6.99	75.50	-
P/OCF Ratio	8.58	13.34	5.32	6.97	73.72	-
EV/Sales Ratio	0.68	1.05	0.32	0.29	0.67	-
EV/EBITDA Ratio	3.88	7.14	2.55	2.41	5.43	-
EV/EBIT Ratio	4.01	7.17	2.56	2.43	5.46	-
EV/FCF Ratio	6.48	12.14	3.02	2.29	60.63	-
Debt / Equity Ratio	0.02	0.01	0.03	0.01	0.01	0.01
Debt / EBITDA Ratio	0.04	0.01	0.10	0.05	0.03	0.01
Debt / FCF Ratio	0.06	0.02	0.12	0.06	0.32	0.01
Asset Turnover	3.00	3.08	2.33	1.14	2.45	3.95
Inventory Turnover	10.38	13.79	14.86	25.73	64.57	-
Quick Ratio	4.27	5.33	5.43	4.53	5.72	1.51
Current Ratio	5.37	5.96	5.80	4.96	6.08	1.61
Return on Equity (ROE)	45.86%	38.79%	27.95%	12.21%	32.44%	98.09%
Return on Assets (ROA)	31.95%	28.12%	18.08%	8.48%	18.85%	29.62%
Return on Capital (ROIC)	39.85%	33.27%	21.73%	10.29%	27.20%	82.52%
Return on Capital Employed (ROCE)	52.40%	45.50%	31.40%	15.60%	27.20%	89.50%
Earnings Yield	12.75%	8.50%	17.00%	9.90%	10.87%	-
FCF Yield	11.19%	7.00%	18.32%	14.30%	1.32%	-
Dividend Yield	2.62%	1.93%	4.16%	1.58%	1.11%	-
Payout Ratio	16.92%	15.53%	16.54%	13.20%	-	-
Buyback Yield / Dilution	-3.97%	-0.89%	-0.46%	-25.23%	-13.15%	-
Total Shareholder Return	-1.35%	1.05%	3.71%	-23.65%	-12.04%	-

Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.